4.6 Review

Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death

Journal

FRONTIERS IN ONCOLOGY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2020.00409

Keywords

cancer; metabolism; microenvironment; metastasis; therapy

Categories

Ask authors/readers for more resources

Since the earliest findings of Otto Warburg, who discovered the first metabolic differences between lactate production of cancer cells and non-malignant tissues in the 1920s, much time has passed. He explained the increased lactate levels with dysfunctional mitochondria and aerobic glycolysis despite adequate oxygenation. Meanwhile, we came to know that mitochondria remain instead functional in cancer cells; hence, metabolic drift, rather than being linked to dysfunctional mitochondria, was found to be an active act of direct response of cancer cells to cell proliferation and survival signals. This metabolic drift begins with the use of sugars and the full oxidative phosphorylation via the mitochondrial respiratory chain to form CO2, and it then leads to the formation of lactic acid via partial oxidation. In addition to oncogene-driven metabolic reprogramming, the oncometabolites themselves alter cell signaling and are responsible for differentiation and metastasis of cancer cells. The aberrant metabolism is now considered a major characteristic of cancer within the past 15 years. However, the proliferating anabolic growth of a tumor and its spread to distal sites of the body is not explainable by altered glucose metabolism alone. Since a tumor consists of malignant cells and its tumor microenvironment, it was important for us to understand the bilateral interactions between the primary tumor and its microenvironment and the processes underlying its successful metastasis. We here describe the main metabolic pathways and their implications in tumor progression and metastasis. We also portray that metabolic flexibility determines the fate of the cancer cell and ultimately the patient. This flexibility must be taken into account when deciding on a therapy, since singular cancer therapies only shift the metabolism to a different alternative path and create resistance to the medication used. As with Otto Warburg in his days, we primarily focused on the metabolism of mitochondria when dealing with this scientific question.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors

Ulrike Wokoun, Martin Hellriegel, Guenter Emons, Carsten Gruendker

ONCOLOGY REPORTS (2017)

Review Endocrinology & Metabolism

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis

Carsten Gruendker, Guenter Emons

FRONTIERS IN ENDOCRINOLOGY (2017)

Review Endocrinology & Metabolism

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Rainer Girgert, Guenter Emons, Carsten Gruendker

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Obstetrics & Gynecology

Mechanisms of Metastasis and Cell Mobility - The Role of Metabolism

Carsten Gruendker, Matthias Laesche, JohannaW. Hellinger, Guenter Emons

GEBURTSHILFE UND FRAUENHEILKUNDE (2019)

Article Obstetrics & Gynecology

Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells

Carsten Gruendker, Ulrike Wokoun, Martin Hellriegel, Guenter Emons

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2019)

Article Oncology

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion

Johanna W. Hellinger, Silke Huechel, Lena Goetz, Gerd Bauerschmitz, Guenter Emons, Carsten Gruendker

FRONTIERS IN ONCOLOGY (2019)

Article Multidisciplinary Sciences

Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling

Johanna W. Hellinger, Franziska Schoemel, Judith Buse, Christof Lenz, Gerd Bauerschmitz, Guenter Emons, Carsten Gruendker

SCIENTIFIC REPORTS (2020)

Article Cell Biology

Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells

Katharina Kolb, Johanna Hellinger, Maike Kansy, Florian Wegwitz, Gerd Bauerschmitz, Guenter Emons, Carsten Gruendker

CELLS (2020)

Review Cell Biology

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer

Carsten Gruendker, Guenter Emons

Summary: The HPG axis regulates the female menstrual cycle through GnRH, which can impact ovarian cancer either indirectly through the HPG axis or directly through receptors on the surface of tumor cells.

CELLS (2021)

Review Cell Biology

The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer

Gunter Emons, Carsten Gruendker

Summary: Endometrial cancer expresses GnRH and its receptor, which can regulate proliferation, the cell cycle, and apoptosis. GnRH agonists are used in fertility preserving therapy for early EC, but show limited activity in advanced or recurrent EC. Further clinical trials exploring the GnRH-system in EC may be beneficial.

CELLS (2021)

Review Cell Biology

HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review

Matthias Laesche, Horst Urban, Julia Gallwas, Carsten Gruendker

Summary: Cervical cancer is mainly caused by long-term infection of HPV virus, with weakened immune system and damaged cervical mucosa being crucial factors for carcinogenesis. Aberrant microbial microenvironment, immune and metabolic signalling are pathological mechanisms of cervical cancer.

CELLS (2021)

Article Cell Biology

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells

Friederike Steifensand, Julia Gallwas, Gerd Bauerschmitz, Carsten Gruendker

Summary: Increased glucose requirement and upregulated glutaminolysis play crucial roles in cancer cell survival, making combined metabolic treatments a potentially effective strategy for improving therapy outcomes in estrogen receptor alpha-positive breast cancer.

CELLS (2021)

Review Biochemistry & Molecular Biology

Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer

Matthias Laesche, Julia Gallwas, Carsten Gruendker

Summary: Despite precautionary measures and vaccinations, HPV-related cancers still remain a significant concern. Research and therapy efforts are needed to address the challenges posed by this disease. HPV infection has the ability to evade immune recognition and utilize host cells for replication. Understanding the effects of HPV infection on metabolic, hormonal, and immune signaling pathways can provide insights into the development of cervical cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

No Data Available